Ceesay Abraham sold RAPP
July 27, 2026 · Form 4 insider transaction
Ceesay Abraham sold 7 shares of Rapport Therapeutics, Inc. at $42.73 per share, a transaction worth $299.15. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7
Price
$42.73
Total value
$299.15
InsiderCeesay Abraham
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 27, 2026
Filing dateJuly 29, 2026
Shares owned after537,607
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.